Skip to content

LeMaitre Vascular LMAT Net Investment in Lease

Net Investment in Lease at other companies

ITG
Integer HoldingsITGR
Merit Medical Systems logo
Merit Medical SystemsMMSI
Abbott logo
AbbottABT
Baxter International logo
Baxter InternationalBAX
Edwards Lifesciences logo
Edwards LifesciencesEW
TFX
TeleflexTFX

Other financials

Income statement

See full
Revenue$66.6M+11.2%
Gross profit$48.4M+16.8%
Operating income$17.8M+40.8%
Net income$15.7M+42.4%
EPS (diluted)$0.68+41.7%

Balance sheet

See full
Cash & equivalents$26.9M+6.0%
Total debt$20.9M+20.6%
Total equity$406.6M+17.0%
Total assets$629.5M+13.2%

Cash flow

See full
Operating cash flow$15.1M+67.0%
CapEx$2.8M+101%
Free cash flow$12.3M+60.8%

Valuation

See full
Market cap$2.1B+31.4%
Enterprise value$2.1B+31.6%
P/E33.7×-1.7×
P/S8.2×+1.1×

Profitability

See full
Gross margin72.4%+3.6pp
Operating margin28.5%+5.1pp
Net margin24.3%+4.4pp
FCF margin30.9%+12.7pp

Returns & leverage

See full
Return on equity16.5%+2.8pp
Debt / equity0.1×0.0×
Current ratio14.3×-2.2×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LeMaitre Vascular's net investment in lease?
LeMaitre Vascular (LMAT) reported net investment in lease of $19.83M in Q1 2026.
How has LeMaitre Vascular's net investment in lease changed year-over-year?
LeMaitre Vascular's net investment in lease increased by 22.2% year-over-year, from $16.23M to $19.83M.
What is the long-term trend for LeMaitre Vascular's net investment in lease?
Over 5 years (2020 to 2025), LeMaitre Vascular's net investment in lease has grown at a -0.4% compound annual growth rate (CAGR), from $16.07M to $15.76M.